NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing essential chemical building blocks for the pharmaceutical industry, particularly in the realm of drug discovery. Among these crucial components, Fmoc-Tyr(HPO3Bzl)-OH emerges as a significant pharmaceutical intermediate, underpinning advancements in therapeutic research and development.
The journey from identifying a biological target to developing a viable drug candidate is complex and often involves intricate chemical synthesis. Pharmaceutical intermediates are the critical molecular scaffolds upon which drug molecules are built. Fmoc-Tyr(HPO3Bzl)-OH, a specialized phosphorylated amino acid derivative, plays a pivotal role in this process, especially in the synthesis of peptide-based drugs and molecules that target specific phosphorylation-dependent pathways. Researchers looking to secure a reliable supply to buy Fmoc-Tyr(HPO3Bzl)-OH find NINGBO INNO PHARMCHEM CO.,LTD. a trusted source.
The significance of Fmoc-Tyr(HPO3Bzl)-OH lies in its ability to accurately represent phosphorylated tyrosine residues, which are key regulators in many cellular signaling cascades. Dysregulation of these pathways is often associated with diseases such as cancer, metabolic disorders, and autoimmune conditions. By incorporating this derivative into synthetic peptides or small molecules, medicinal chemists can design compounds that modulate these pathways with high specificity. This targeted approach is central to modern drug discovery, aiming for greater efficacy and reduced side effects.
The use of the Fmoc (9-fluorenylmethoxycarbonyl) protecting group is a hallmark of efficient and mild peptide synthesis, particularly within Solid Phase Peptide Synthesis (SPPS). Fmoc-Tyr(HPO3Bzl)-OH, by adhering to this chemistry, ensures that its incorporation into complex molecular structures is straightforward and high-yielding. This compatibility with established synthetic protocols makes it an attractive intermediate for pharmaceutical companies aiming to streamline their research and development pipelines. The competitive Fmoc-Tyr(HPO3Bzl)-OH price from NINGBO INNO PHARMCHEM CO.,LTD. further enhances its appeal for large-scale synthesis projects.
Furthermore, this compound serves as a valuable tool for creating phosphopeptide libraries, which are instrumental in screening for novel drug targets and lead compounds. These libraries allow for the rapid evaluation of numerous molecular variations, accelerating the identification of promising therapeutic candidates. Access to consistent and high-purity Fmoc-Tyr(HPO3Bzl)-OH from a reliable Fmoc-Tyr(HPO3Bzl)-OH supplier is paramount for the success of such screening efforts.
In summary, Fmoc-Tyr(HPO3Bzl)-OH is a critical pharmaceutical intermediate that empowers drug discovery initiatives. Its precise chemical structure, coupled with the advantageous Fmoc protection strategy, makes it an essential component for synthesizing targeted therapeutics and exploring complex biological pathways. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing the quality materials needed to advance pharmaceutical innovation.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.